Restoration of Foveal Bulge after Resolution of Diabetic Macular Edema with Coexisting Serous Retinal Detachment

Table 1

Baseline characteristics of diabetic macular edema eyes with coexisting serous retinal detachment in foveal bulge (+) group and foveal bulge (-) group.

	Foveal bulge (+) ()	Foveal bulge (−) ()
Mean age (SD) (years)	54.64 (8.83)	56.67 (13.50)	0.134^†
Mean IOP (SD) (mmHg)	14.12 (2.19)	15.07 (2.73)	0.132^†
Mean time since diagnosis of DM (SD) (years)	7.72 (3.71)	9.04 (5.42)	0.568^†
Mean duration of DME before IVR (SD) (months)	7.99 (6.43)	10.50 (7.43)	0.161^†
Mean HbA1C (SD) (%)	8.09 (1.30)	8.66 (2.60)	0.761^†
Diabetic retinopathy severity ( (%))			0.746^‡
NPDR	15 (60.0%)	15 (55.6%)
PDR	10 (40.0%)	12 (44.4%)
Photocoagulation treatment ( (%))	13 (52.0%)	14 (51.9%)	0.991^‡
Mean baseline BCVA (SD) (logMAR/Snellen VA)	0.46 (0.24)/≈20/57.7	0.52 (0.15)/≈20/66.2	0.135^†
Mean baseline CFT (SD) (μm)	533.84 (178.69)	587.37 (235.75)	0.589^†
Mean baseline SRDH (SD) (μm)	214.96 (85.01)	308.11 (186.27)	0.040^†

^†Unpaired Mann-Whitney test; ^‡Chi-square test. IOP: intraocular pressure; DM: diabetic mellitus; IVR: intravitreal injection of ranibizumab; HbA1c: glycosylated hemoglobin; NPDR: nonproliferative diabetic retinopathy; PDR: proliferative diabetic retinopathy; BCVA: best-corrected visual acuity; Snellen VA: Snellen visual acuity; CFT: central foveal thickness; SRDH: height of serous retinal detachment; SD standard deviation.